Home > News > Why biotech CEOs need to think like Steve Jobs
August 25th, 2007
Why biotech CEOs need to think like Steve Jobs
Abstract:
The company is engineering nanoscale particles that will deliver two drugs directly to the site of a tumor: One drug will shut down the blood vessels that feed the tumor while the other will deliver chemotherapy over a sustained period. By custom-building the package that will contain these two drugs, Tempo believes it can get the drugs to the right place -- and reduce side effects.
"Nanotechnology," Crane said, "has the potential to redefine drug therapy over the next five to 10 years."
Source:
boston.com
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||